Assessment of axillary lymph node involvement in early breast cancer. Analysis of a predictive model includinq 893 cases;Évaluation du risque d'envahissement ganglionnaire axillaire dans les cancers du sein inférieurs à 3 centimètres. Analyse d'un modèle prédictif à partir de 893 cas

Chirurgie

Volumn 123, Issue 2, 1998, Pages 175-182

  Cutuli, B ^a   Velten, M ^a   Rodier, J F ^a   Janser, J C ^a   Quetin, P ^a   Jaeck, D ^b   Renaud, R ^b   Duperoux, G ^a  

^a CENTRE PAUL STRAUSS   (France)

^b NONE

Author keywords

Axillary involvement; Breast cancer; Breast size; Lymph nodes; Sentinel node

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CLINICAL TRIAL; FEMALE; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MODEL; MULTIVARIATE ANALYSIS; PROGNOSIS;

EID: 0031776657     PISSN: 00014001     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4001(98)80103-7     Document Type: Article

References (44)

1. Fentiman IS, Epstein R, Barr L. Is routine axillary nodal dissection necessary in the tratment of breast cancer? Eur J Cancer 1996 ; 32A : 1460-3
2. FNCLCC - Standards, Options et Recommandations Vol 3. Cancers du sein non métastatiques. Paris : Arnette Blackwell ; 1996
3. Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. Eur J Cancer 1992 ; 28A : 1415-8
4. Cabanes PA, Salmon RJ, Vilcoq JR, Durand JC, Fourquet A, Gautier C et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 1992 ; 339 : 1245-8
5. Graversen HP, Blichert-Toft M, Andersen JA, Zedeler K and the Danish Breast Cancer Co-operative Group. Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axilla. Eur J Surg Oncol 1988 ; 14 : 407-2
6. Kissin W, Thompson EM, Price AB, Slavin G, Kark AE. The inadequacy of axillary sampling in breast cancer. Lancet 1982 ; 51 : 1210-1
7. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M. The accuracy of clinical staging and of limited axillary dissection as a determinant of histological nodal status in carcinoma of breast. Surg Gynecol Obstet 1981 ; 152 : 756-72
8. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997 ; 337 : 949-55
9. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997 ; 337 : 956-62
10. Cady B, Stone MD, Schudel JG, Thakur R, Wanner MA, Lavin PT. The new era in breast cancer: invasion, size and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 1996 ; 131 : 301-8
11. Carter CL, Allen C, Henson D. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 1989; 63 : 181-7
12. Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 1997; 79: 1918-22
13. Chadha M, Chabon AB, Friedmann P, Viskram B. Predictors of axillary lymph node metastases in patients with T1 breast cancer. Cancer 1994 ; 73 : 350-3
14. Ranaboldo CJ, Mitchel A, Royle GT, Theaker GM, Taylor I. Axillary nodal status in women with screen-detected breast cancer. Eur J Surg Oncol 1993 ; 19 : 130-3
15. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer. A review. Cancer 1995 ; 76 : 1491-1512
16. Strom EA, McNeese MD, Fletcher GH. Treatment of the peripheal lymphatics : rational indications and techniques. In: GH Fletcher, SH Levitt, eds. Non-disseminated breast cancer. Controversial issues in management. Berlin : Springer-Verlag ; 1993. p 57-72
17. Veronesi U, Luini A, Galimberti V, Marchini S, Sacchini V, Rilke F. Extent of metastatic axillary involvement in 1,446 cases of breast cancer. Eur J Surg Oncol 1990 ; 16 : 127-33
18. Chauvet B, Simon JM, Reynaud-Bougnoux A, Deschamps P, Calais G, Lansac J et al. Recidives mammaires après traitement conservateur des cancers du sein : facteurs prédictifs et signification pronostique. Bull Cancer 1990 ; 77 : 1193-1205
19. Cutuli B, Velten M, Karst A, Jaeck D, Renaud R, Rodier JF. Dosimetric breast size: a new useful parameter for the prediction of local recurrence after breast conservative treatment. Eur J Cancer 1997 ; 33 : 2432-4
20. Boova RS, Bonanni R, Rosato FE. Patterns of axillary nodal involvement in breast cancer. Predictability of level one dissection. Ann Surg 1982; 196 : 642-4
21. Bucalossi P, Veronesi U, Zingo L, Cantù C. Enlarged mastectomy for breast cancer. Ann Surg 1971 ; 111 : 119-22
22. Contesso G, Rouesse J, Genin J. L'envahissement ganglionnaire locorégional des cancers du sein. Bull Cancer 1975 ; 62 : 359-72
23. Veronesi U, Rilke F, Luini A, Sacchini V, Galimberti V, Campa T et al. Distribution of axillary node metastases by level of invasion. An analysis of 539 cases. Cancer 1987 ; 59 : 682-7
24. Rosen PP, Lesser ML, Kinne DW, Beattie EJ. Discontinous or « skip » metastases in breast carcinoma: analysis of 1,228 axillary dissections. Ann Surg 1983 ; 197 : 276-83
25. Gaglia P, Bussone R, Caldarola B, Lai M, Jayme A, Caldarola L. The correlation between the spread of metastases by level in the axillary nodes and disease-free survival in breast cancer. A multifactorial analysis. Eur J Cancer Clin Oncol 1987 ; 23 : 849-54
26. Danforth DN, Findlay PA, McDonald HD, Lippman ME, Reichert CM, d'Angelo J et al. Complete axillary lymph node dissection for stage I-II carcinoma of the breast. J Clin Oncol 1986 ; 4 : 655-62
27. Pigott, Nichols R, Maddox WA, Balch CL. Metastases of the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures. Surg Gynecol Obstet 1984 ; 158 : 255-9
28. Mathiesen O, Carl J, Bonderup O, Panduro J. Axillary sampling and the risk of erroneous staging of breast cancer. Acta Oncol 1990 ; 29 : 721-5
29. Kiricuta IC, Tausch J. A mathematical model of the axillary lymph node involvement based on 1,446 completa axillary dissections in patients with breast carcinoma. Cancer 1992 ; 69 : 2496-2501
30. Dees EC, Shulman LN, Souba WW, Smith BL. Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorythm for assessment of impact of axillary dissection. Ann Surg 1997 ; 226 : 279-87
31. Fentiman IS, Hyland D, Chaudary MA, Gregory WM. Prognosis of patients with breast cancers up to 1 cm in diameter. Eur J Cancer 1996 ; 32A : 417-20
32. Van Thienoven G, Borger JH, Passchier DH, Hart AA, Rutgers EJ, Van Dongen JA et al. The prognostic significance of the axillary apex biopsy in clinically operable breast cancer. Eur J Cancer 1995 ; 31A : 1965-8
33. Ciatto S, Rosselli del Turco M, Bonardi R, Cataliotti L, Distante V, Cardona G et al. Non-palpable lesions of the breast detected by mammography. Review of 1182 consecutive histologically confirmed cases. Eur J Cancer 1994 ; 30A : 40-4
34. Le Bouedec G, Pomel C, Chamussy E, Feillel V, de Latour M, Dauplat J. Le curage ganglionnaire axillaire dans les cancers infracliniques du sein. Bull Cancer 1996 ; 83 : 581-8
35. Sher CJ, Egan MK, Smith P, Wicks K, Millis RR, Fentiman IS. Histopathology of breast cancer in relation to age. Br J Cancer 1997 ; 75 : 593-6
36. Halverson KJ, Taylor ME, Perez CA, Garcia DM, Myerson R, Philpott G et al. Management of the axilla in patients with breast cancers one centimeter or smaller. Am J Clin Oncol 1994 ; 17 : 461-6
37. Veronesi V, Paganelli G, Galimberti V, Viale G, Zurrda S, Bedoni M et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997 ; 349 : 1864-7
38. Thurfjell E, Hsieh CC, Lipworth L, Ekbom A, Adami HO, Trichopulos D. Breast size and mammographic pattern in relation to breast cancer risk. Eur J Cancer Prevent 1996 ; 5 : 37-41
39. Ravdin PM, de Laurentiis M, Vendely T, Clark GM. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst 1994 ; 86 : 1771-5
40. Renolleau C, Merviel P, Clough KB, Asselain B, Campana F, Durand JC. Isolated axillary recurrences after conservative treatment of breast cancer. Eur J Cancer 1996 ; 32A : 617-21
41. Fisher BJ, Perera FE, Cooke AL, Opeitum A, Venkatesan V, Dar AR et al. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence. Int J Radiat Oncol Biol Phys 1997 ; 38 : 541-50
42. Gardner B, Feldman J. Are positive axillary nodes in breast cancer markers for incurable disease? Ann Surg 1993 ; 218 : 270-8
43. Sacks NPM, Barr LC, Allan SM, Baum M. The role of axillary dissection in operable breast cancer. Breast 1992 ; 1 : 41-9
44. Wilking N, Rutquist LE, Carstensen J, Mattsson A, Skoog L. Prognostic significance of axillary nodal status in primary breast cancer in relation to member of resected nodes. Acta Oncol 1992 ; 31 : 29-35